158 related articles for article (PubMed ID: 31782884)
1. ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation.
Nicolai S; Pieraccioli M; Smirnov A; Pitolli C; Anemona L; Mauriello A; Candi E; Annicchiarico-Petruzzelli M; Shi Y; Wang Y; Melino G; Raschellà G
Mol Oncol; 2020 Feb; 14(2):294-308. PubMed ID: 31782884
[TBL] [Abstract][Full Text] [Related]
2. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; Raschellà G; Melino G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555
[TBL] [Abstract][Full Text] [Related]
3. Zfp281 Shapes the Transcriptome of Trophoblast Stem Cells and Is Essential for Placental Development.
Ishiuchi T; Ohishi H; Sato T; Kamimura S; Yorino M; Abe S; Suzuki A; Wakayama T; Suyama M; Sasaki H
Cell Rep; 2019 May; 27(6):1742-1754.e6. PubMed ID: 31067460
[TBL] [Abstract][Full Text] [Related]
4. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
5. Multi-functional gene ZNF281 identified as a molecular biomarker in soft tissue regeneration and pan-cancer progression.
Hou X; Luan J; Fu S
Front Genet; 2022; 13():1082654. PubMed ID: 36685971
[TBL] [Abstract][Full Text] [Related]
6. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
[TBL] [Abstract][Full Text] [Related]
7. ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancer.
Hahn S; Hermeking H
J Mol Med (Berl); 2014 Jun; 92(6):571-81. PubMed ID: 24838609
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.
Rota R; Ciarapica R; Giordano A; Miele L; Locatelli F
Mol Cancer; 2011 Sep; 10():120. PubMed ID: 21943149
[TBL] [Abstract][Full Text] [Related]
9. CircAGFG1 sponges miR-203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression.
Xue YB; Ding MQ; Xue L; Luo JH
Thorac Cancer; 2019 Aug; 10(8):1692-1701. PubMed ID: 31243884
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-ZNF281 Interacts with miR-539 to Promote Hepatocellular Carcinoma Cell Invasion and Migration.
Zhang Z; Yang L; Yao X; Yang M; Li G
Cancer Biother Radiopharm; 2020 Mar; 35(2):137-142. PubMed ID: 32073896
[No Abstract] [Full Text] [Related]
11. ZNF281 knockdown induced osteogenic differentiation of human multipotent stem cells in vivo and in vitro.
Seo KW; Roh KH; Bhandari DR; Park SB; Lee SK; Kang KS
Cell Transplant; 2013; 22(1):29-40. PubMed ID: 22963690
[TBL] [Abstract][Full Text] [Related]
12. Osteoglycin inhibition by microRNA miR-155 impairs myogenesis.
Freire PP; Cury SS; de Oliveira G; Fernandez GJ; Moraes LN; da Silva Duran BO; Ferreira JH; Fuziwara CS; Kimura ET; Dal-Pai-Silva M; Carvalho RF
PLoS One; 2017; 12(11):e0188464. PubMed ID: 29161332
[TBL] [Abstract][Full Text] [Related]
13. Cell Density and Joint microRNA-133a and microRNA-696 Inhibition Enhance Differentiation and Contractile Function of Engineered Human Skeletal Muscle Tissues.
Cheng CS; Ran L; Bursac N; Kraus WE; Truskey GA
Tissue Eng Part A; 2016 Apr; 22(7-8):573-83. PubMed ID: 26891613
[TBL] [Abstract][Full Text] [Related]
14. Myogenic transcription factors regulate pro-metastatic miR-182.
Dodd RD; Sachdeva M; Mito JK; Eward WC; Brigman BE; Ma Y; Dodd L; Kim Y; Lev D; Kirsch DG
Oncogene; 2016 Apr; 35(14):1868-75. PubMed ID: 26234681
[TBL] [Abstract][Full Text] [Related]
15. miR-98 delays skeletal muscle differentiation by down-regulating E2F5.
Kropp J; Degerny C; Morozova N; Pontis J; Harel-Bellan A; Polesskaya A
Biochem J; 2015 Feb; 466(1):85-93. PubMed ID: 25422988
[TBL] [Abstract][Full Text] [Related]
16. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
17. Target identification of microRNAs expressed highly in human embryonic stem cells.
Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
[TBL] [Abstract][Full Text] [Related]
18. miR-423-5p inhibits myoblast proliferation and differentiation by targeting Sufu.
Ge J; Zhu J; Xia B; Cao H; Peng Y; Li X; Yu T; Chu G; Yang G; Shi X
J Cell Biochem; 2018 Sep; 119(9):7610-7620. PubMed ID: 29923621
[TBL] [Abstract][Full Text] [Related]
19. MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation.
Zhao MJ; Xie J; Shu WJ; Wang HY; Bi J; Jiang W; Du HN
Cell Death Dis; 2019 Feb; 10(3):183. PubMed ID: 30796205
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1.
Luo Z; Wen G; Wang G; Pu X; Ye S; Xu Q; Wang W; Xiao Q
Stem Cells; 2013 Sep; 31(9):1749-62. PubMed ID: 23765923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
